Malvern, Penn.-based Yaupon Therapeutics Inc. has closed on $14.4 million in Series D financing. The company, a specialty pharmaceutical maker, is backed by Vivo Ventures, Palo Alto Investors, Burrill & Company and Aperture Venture Partners. The new funds will help the company go through the regulatory review process for a drug designed to treat early stage mycosis fungoides, the most common type of cutaneous T-cell lymphoma.

Revance Therapeutics Inc., a drug developer focused on dermatology and aesthetic medicine, has raised $45 million in new capital from Essex Woodlands Health Ventures, NovaQuest Capital, CNF Investments, Vivo Ventures, Technology Partners, Shepherd Ventures, Palo Alto Investors, Pac-Link Ventures and Essex Capital Corporation. Jonathan Tunnicliffe, a partner at NovaQuest, will join the Revance board as a result of the round. Revance closed a $25.62 million in Series D funding in late 2009.

Sex toy maker JimmyJane raised $2 million from a group of investors in its Series E round, according to a new regulatory filing. This brings the company’s total to $8.3 million.

JimmyJane, a startup looking to become the Montblanc of vibrating sex toys, has raised money from investors such as technology hedge fund Palo Alto Investors and a limited liability company controlled by venture capitalist Tim Draper, documents show.

Since its initial institutional financing round, the company has launched several new products. Its original line of high-end toys were pricey, starting at $175 and ranging up to $3,250 for its diamond-studded platinum vibrator. It has since added several down-market offerings, such as a the $90 “Iconic Rabbit” and a $36 vibrating ring.

The electric car wars continue as Fisker Automotive gets a $65 million cash injection from Kleiner Perkins, hedge fund Palo Alto Investors and the Qatar Investment Authority (QIA). Earth2Tech has the story and a reminder about the company’s ongoing legal battle.

The interesting thing here, outside the sexy looking car, is the source of the financing: an early stage venture firm (now growth investor when it comes to “greentech”), a hedge fund and the state-backed investment fund of an petrochemical-rich middle-eastern nation. Which of these investors doesn’t belong?